THC — Tenet Healthcare Corporation stock price and chart

THC

Tenet Healthcare CorporationStock · Health CareRussell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02%

$261.99+0.03%

as of Sep 21, 9:35 AM ET

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

Volume

20162019202120242026

50.0100.0150.0200.0250.0020.0M40.0M$262.59

2026-09-21

Price$262.59

MA20$214.93

MA50$204.89

Vol5.0M

What would $1,000 invested in THC be worth today? →

THC returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $262.59
Change YTD: +31.84%
Next earnings: Oct 27, 2026
Market cap: 21.1B2016-09 2.3B2026-09 21.1B+834.3% over the window
Enterprise value: 35.8B
Shares outstanding: 80.5M2016-06 99.5M2026-06 80.5M-19.1% over the window
52W low: $157.58
52W high: $283.05
From 52W high: -7.44%
From 52W low: +66.64%
52W range: 84%
Beta: 1.22

Volume

Rel volume: 3.99×
30D volume: 798.4K
30D $ vol: 212.2M

Fundamentals

Sales (ttm): 21.8B2016-12 21.1B2026-06 21.8B+3.5% over the window
Sales/share: $270.892016-12 $211.092026-06 $270.89+28.3% over the window
FCF (ttm): 3B2016-06 359M2026-06 3B+742.1% over the window
FCF/share: $37.542016-06 $3.612026-06 $37.54+940.8% over the window
Book value/share: $57.852016-06 $5.262026-06 $57.85+1000.8% over the window
Debt / equity: 2.81×2016-06 27.382026-06 2.81-89.7% over the window
Current ratio: 1.412016-06 1.132026-06 1.41+24.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +5.41%2025-06-30 → 2026-06-3020.7B → 21.8B (+5.4% total)+3.11%2023-06-30 → 2026-06-3019.9B → 21.8B (+9.6% total)+2.58%2021-06-30 → 2026-06-3019.2B → 21.8B (+13.6% total)+0.37%2016-12-31 → 2026-06-3021.1B → 21.8B (+3.5% total)
Net income: -56.06%2024-12-31 → 2025-12-313.2B → 1.4B (-56.0% total)+50.70%2022-12-31 → 2025-12-31411M → 1.4B (+242.3% total)+12.87%2020-12-31 → 2025-12-31768M → 1.4B (+83.2% total)+33.54%2015-12-31 → 2025-12-3178M → 1.4B (+1703.8% total)
FCF: +94.74%2025-06-30 → 2026-06-301.6B → 3B (+94.7% total)+46.51%2023-06-30 → 2026-06-30961M → 3B (+214.6% total)+17.97%2021-06-30 → 2026-06-301.3B → 3B (+128.5% total)+23.75%2016-06-30 → 2026-06-30359M → 3B (+742.1% total)
Shares: -8.87%2025-06-30 → 2026-06-3088.4M → 80.5M (-8.9% total)-7.44%2023-06-30 → 2026-06-30101.5M → 80.5M (-20.7% total)-5.54%2021-06-30 → 2026-06-30107.1M → 80.5M (-24.8% total)-2.10%2016-06-30 → 2026-06-3099.5M → 80.5M (-19.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -52.65%2024-12-31 → 2025-12-31$32.70 → $15.49 (-52.6% total)+59.87%2022-12-31 → 2025-12-31$3.79 → $15.49 (+308.7% total)+32.81%2020-12-31 → 2025-12-31$3.75 → $15.49 (+313.1% total)n/a
Sales/share: +15.67%2025-06-30 → 2026-06-30$234.21 → $270.89 (+15.7% total)+11.40%2023-06-30 → 2026-06-30$195.93 → $270.89 (+38.3% total)+8.59%2021-06-30 → 2026-06-30$179.41 → $270.89 (+51.0% total)+2.66%2016-12-31 → 2026-06-30$211.09 → $270.89 (+28.3% total)
FCF/share: +113.70%2025-06-30 → 2026-06-30$17.58 → $37.54 (+113.6% total)+58.28%2023-06-30 → 2026-06-30$9.46 → $37.54 (+296.7% total)+24.89%2021-06-30 → 2026-06-30$12.36 → $37.54 (+203.8% total)+26.40%2016-06-30 → 2026-06-30$3.61 → $37.54 (+940.8% total)
Book value/share: +36.36%2025-06-30 → 2026-06-30$42.43 → $57.85 (+36.3% total)+63.52%2023-06-30 → 2026-06-30$13.23 → $57.85 (+337.4% total)+88.40%2021-06-30 → 2026-06-30$2.44 → $57.85 (+2272.8% total)+27.11%2016-06-30 → 2026-06-30$5.26 → $57.85 (+1000.8% total)
Price: +35.45%2025-09-22 → 2026-09-21$194.06 → $262.59 (+35.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+57.39%2023-09-21 → 2026-09-21$67.33 → $262.59 (+290.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+29.33%2021-09-21 → 2026-09-21$72.58 → $262.59 (+261.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+28.12%2016-09-20 → 2026-09-21$22.02 → $262.59 (+1092.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +35.45%2025-09-22 → 2026-09-21$194.06 → $262.59 (+35.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+57.39%2023-09-21 → 2026-09-21$67.33 → $262.59 (+290.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+29.33%2021-09-21 → 2026-09-21$72.58 → $262.59 (+261.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+28.12%2016-09-20 → 2026-09-21$22.02 → $262.59 (+1092.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 4.6×2016-09 1.732026-09 4.65+168.2% over the window
Fwd P/E: 12.6×
P/S (ttm)Market cap ÷ TTM revenue.: 1.0×2017-03 0.082026-09 0.97+1044.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.5×2016-09 4.282026-09 4.53+5.9% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 7.0×2016-09 14.852026-09 6.98-53.0% over the window
EV/EBITDA (fy): 6.6×
EV/Sales (ttm): 1.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 14.30%2016-06 15.9%2026-06 20.1%+26.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 80.5M ÷ 88.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 8.87%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (8.87%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($15.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 8.87%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.7B) ÷ today's market cap ($21.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 7.81%2016-06 1.8%2026-06 11.0%+518.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.7B + TTM dividends $0) ÷ today's market cap ($21.1B). Same caveat as the cash buyback yield.: 7.81%2016-06 1.8%2026-06 11.0%+518.6% over the window

Vs own 10Y history

P/E: 83rd
P/OI: 94th
P/S: 99th
P/B: 47th
P/FCF: 49th

Bar = where today’s multiple sits in THC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

+0.03%

-0.64%

-3.04%

+51.82%

YTD

+31.84%

+37.68%

+259.38%

Financial statements

Open full THC financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-9.18%	-0.38%
NVO	Novo Nordisk A/S	-5.40%	+0.12%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-1.82%	-1.66%
SNY	Sanofi ADS	-7.11%	+0.26%
ARGX	argenx SE American Depositary Shares	-4.83%	-0.07%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	+4.76%	-0.71%
NTRA	Natera Inc.	+18.51%	+0.84%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+6.56%	-0.48%

Tenet Healthcare Corporation (THC) trades at $261.99 with a live price and an interactive chart covering 44+ years of daily price history, plus key valuation metrics. ChartRow also publishes THC’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full THC financial statements →

THC — Tenet Healthcare Corporation price, chart and key statistics

Key stats

Price data

Volume

Fundamentals

Growth (CAGR, ttm) · 10Y

Per-share growth (CAGR, ttm) · 10Y

Valuation

Vs own 10Y history

Performance · price return · as of 2026-09-18

Financial statements

Related Health Care